Amyloidosis 2008 BMT Tandem Meetings (February 13-17, San Diego)

Por Dispenzieri, Angela, Merlini, Giampaolo, Comenzo, Raymond L.
Publicado em 2008

Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium

Por Lousada, Isabelle, Comenzo, Raymond L., Landau, Heather, Guthrie, Spencer, Merlini, Giampaolo
Publicado no Adv Ther (2015)

Patient experience with hereditary and senile systemic amyloidoses: a survey from the Amyloidosis Research Consortium

Por Lousada, Isabelle, Comenzo, Raymond L, Landau, Heather, Guthrie, Spencer, Merlini, Giampaolo
Publicado no Orphanet J Rare Dis (2015)

Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan

Por Zhou, Ping, Teruya-Feldstein, Julie, Lu, Ping, Fleisher, Martin, Olshen, Adam, Comenzo, Raymond L
Publicado em 2008

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody–based therapy

Por Zhou, Ping, Comenzo, Raymond L., Olshen, Adam B., Bonvini, Ezio, Koenig, Scott, Maslak, Peter G., Fleisher, Martin, Hoffman, James, Jhanwar, Suresh, Young, James W., Nimer, Stephen D., Boruchov, Adam M.
Publicado em 2008

Autologous Stem Cell Transplant Recipients Tolerate Haploidentical Related-Donor Natural Killer Cell Enriched Infusions

Por Klingemann, Hans, Grodman, Carrie, Cutler, Elliott, Duque, Marvin, Kadidlo, Diane, Klein, Andreas K., Sprague, Kellie A., Miller, Kenneth B., Comenzo, Raymond L., Kewalramani, Tarun, Yu, Neng, Van Etten, Richard A., McKenna, David H.
Publicado em 2012

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)

Por Jaccard, Arnaud, Comenzo, Raymond L., Hari, Parameswaran, Hawkins, Philip N., Roussel, Murielle, Morel, Pierre, Macro, Margaret, Pellegrin, Jean-Luc, Lazaro, Estibaliz, Mohty, Dania, Mercie, Patrick, Decaux, Olivier, Gillmore, Julian, Lavergne, David, Bridoux, Frank, Wechalekar, Ashutosh D., Venner, Christopher P.
Publicado no Haematologica (2014)

Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis

Por Reece, Donna E., Hegenbart, Ute, Sanchorawala, Vaishali, Merlini, Giampaolo, Palladini, Giovanni, Bladé, Joan, Fermand, Jean-Paul, Hassoun, Hani, Heffner, Leonard, Kukreti, Vishal, Vescio, Robert A., Pei, Lixia, Enny, Christopher, Esseltine, Dixie-Lee, van de Velde, Helgi, Cakana, Andrew, Comenzo, Raymond L.
Publicado em 2014

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

Por D'Souza, Anita, Dispenzieri, Angela, Wirk, Baldeep, Zhang, Mei-Jie, Huang, Jiaxing, Gertz, Morie A., Kyle, Robert A., Kumar, Shaji, Comenzo, Raymond L., Peter Gale, Robert, Lazarus, Hillard M., Savani, Bipin N., Cornell, Robert F., Weiss, Brendan M., Vogl, Dan T., Freytes, César O., Scott, Emma C., Landau, Heather J., Moreb, Jan S., Costa, Luciano J., Ramanathan, Muthalagu, Callander, Natalie S., Kamble, Rammurti T., Olsson, Richard F., Ganguly, Siddhartha, Nishihori, Taiga, Kindwall-Keller, Tamila L., Wood, William A., Mark, Tomer M., Hari, Parameswaran
Publicado no J Clin Oncol (2015)